This information is intended for Healthcare Professionals
You will now be re-directed to www.pfizermedicalinformation.com
Vepdegestrant is an investigational compound. Its safety and efficacy have not been established. * Vepdegestrant is being co-developed with Arvinas.
Breast Cancer
Phase 1
NCT05548127
NCT06206837
NCT06125522
NCT05501769
NCT04072952
Breast Neoplasms
NCT05463952
NCT05573555
Phase 2
NCT05549505
Advanced Breast Cancer
Phase 3
NCT05654623
NCT05909397
Back
